QUARTA, ERIDE
 Distribuzione geografica
Continente #
AS - Asia 1.319
NA - Nord America 1.309
EU - Europa 1.204
SA - Sud America 215
AF - Africa 74
OC - Oceania 9
Totale 4.130
Nazione #
US - Stati Uniti d'America 1.264
SG - Singapore 500
IT - Italia 429
CN - Cina 257
VN - Vietnam 254
IE - Irlanda 201
BR - Brasile 164
SE - Svezia 111
HK - Hong Kong 109
DE - Germania 98
NL - Olanda 81
FR - Francia 70
ZA - Sudafrica 47
AT - Austria 40
GB - Regno Unito 35
FI - Finlandia 34
IN - India 32
RU - Federazione Russa 31
BD - Bangladesh 30
TR - Turchia 25
CA - Canada 24
AR - Argentina 21
MX - Messico 16
PL - Polonia 14
ID - Indonesia 13
KR - Corea 12
EC - Ecuador 10
TW - Taiwan 10
ES - Italia 9
IQ - Iraq 8
RS - Serbia 8
MY - Malesia 7
TH - Thailandia 7
UZ - Uzbekistan 7
JP - Giappone 6
MA - Marocco 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
CI - Costa d'Avorio 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IR - Iran 5
JO - Giordania 5
UA - Ucraina 5
BE - Belgio 4
HR - Croazia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CL - Cile 3
GA - Gabon 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
MM - Myanmar 1
MR - Mauritania 1
NG - Nigeria 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 4.130
Città #
Singapore 313
Ashburn 250
Dublin 197
San Jose 134
Parma 126
Dallas 107
Hong Kong 106
Chandler 97
Santa Clara 92
Ho Chi Minh City 74
Hanoi 54
Munich 52
Beijing 50
Shanghai 50
Boardman 47
Johannesburg 44
Milan 39
Ann Arbor 38
Los Angeles 34
Groningen 33
Vienna 30
New York 29
Lauterbourg 26
Bologna 23
Ferrara 22
Turku 22
Hefei 21
Rome 21
Reggio Emilia 20
Da Nang 17
Buffalo 15
Haiphong 15
Brooklyn 13
Chicago 13
Seattle 13
Columbus 12
Frankfurt am Main 12
Guangzhou 12
Princeton 12
Amsterdam 11
Council Bluffs 11
Helsinki 11
Montreal 11
Stockholm 11
Warsaw 11
Des Moines 10
Moscow 10
Jakarta 9
Marseille 9
Mumbai 9
Nuremberg 9
Orem 9
Seoul 9
The Dalles 9
Ardea 8
Mexico City 8
São Paulo 8
Ankara 7
Istanbul 7
Tashkent 7
Thái Bình 7
Atlanta 6
Belgrade 6
Falls Church 6
Houston 6
London 6
Manchester 6
Phoenix 6
Taipei 6
West Jordan 6
Wilmington 6
Abidjan 5
Auckland 5
Bangkok 5
Buenos Aires 5
Denver 5
Fremont 5
Modena 5
Montegaldella 5
Ottawa 5
Padova 5
Puchong Batu Dua Belas 5
Segrate 5
Strasbourg 5
Amman 4
Assago 4
Brescia 4
Bắc Ninh 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Konyaalti 4
Macomer 4
Pune 4
Tokyo 4
Zagreb 4
Asunción 3
Belo Horizonte 3
Bengaluru 3
Bexley 3
Totale 2.671
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 244
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 219
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 197
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 191
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 181
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 164
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 161
Respicell(TM): An innovative dissolution apparatus for inhaled products 150
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 146
Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects 143
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 139
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 132
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 132
Nasal delivery as a strategy for the prevention and treatment of COVID-19 131
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 129
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 127
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 126
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 124
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 120
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 120
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 111
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 107
Polyelectrolyte Complex Dry Powder Formulations of Tobramycin with Hyaluronic Acid and Sodium Hyaluronate for Inhalation Therapy in Cystic Fibrosis-Associated Infections 107
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 102
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 102
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 99
Understanding the importance of capsules in dry powder inhalers 89
Drugs as contaminants of emerging concern: preventive approaches beyond detection, regulatory aspects and remediation 79
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 78
Site-Specific Microparticle Inhalation Therapy: A New Approach to Nasopharyngeal Symptoms 76
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 72
LACTOBACILLI INHALATION POWDER FOR THE REDUCTION OF LUNG INFLAMMATION IN non-CF BRONCHIECTASIS DISEASE 69
Influence of Capsule Size and DPIs Resistance on Inhalable Dry Powder Aerodynamic Performance 31
Totale 4.198
Categoria #
all - tutte 14.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 8 12 2
2021/2022112 3 3 8 5 20 5 12 8 9 1 7 31
2022/2023430 36 49 19 33 27 43 30 35 129 11 9 9
2023/2024438 11 18 8 20 26 59 112 31 24 31 45 53
2024/2025939 28 42 67 101 75 80 79 58 96 72 85 156
2025/20262.143 178 137 313 240 320 142 262 92 327 132 0 0
Totale 4.198